New legislation increases access to medical products for military applications

Today, the President signed new legislation that gives the Department of Defense (DoD) new opportunities to advocate to FDA for expedited development, review, and Emergency Use Authorization (EUA) for medical products that could help protect and treat U.S. military forces.

The legislation was developed as an alternative to a provision in the National Defense Authorization Act for Fiscal Year 2018 (NDAA) that would have given DoD new authority to bypass FDA in authorizing certain unapproved medical products for U.S. armed forces. The new legislation requires greater coordination and collaboration between DoD and FDA and establishes or modifies three FDA programs.

Read more: New Legislation Increases Access to Medical Products for Military Applications 


Download PDF Share Back To Listing
Loading data